Breast cancer adjuvant endocrine treatment
Cottu, P.
La Revue du Praticien 63(10): 1404-1407
2013
ISSN/ISBN: 0035-2640 PMID: 24579339 Document Number: 664131
Endocrine treatment of early stage breast cancer may be summarized in two settings. (1) Early breast cancer, premenopausal women: tamoxifen; ovarian suppression is an acceptable option. (2) Early breast cancer, menopausal women: aromatase inhibitors, for at least 2 to 3 years; extended treatment beyond 5 years of tamoxifen may be discussed.
Document emailed within 1 workday
Related Documents
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712Nesković-Konstantinović, Z.; Filipović, S. 2003: The role of endocrine therapy in early breast cancer: adjuvant treatment of preand postmenopausal patients Journal of Buon: Official Journal of the Balkan Union of Oncology 8(1): 11-17
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Taguchi, T. 1998: Adjuvant for breast cancer chemo-endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 453-467
Jakesz, R.; Hausmaninger, H. 1984: Adjuvant endocrine forms of therapy in breast cancer Wiener Klinische Wochenschrift 96(13): 492-499
Ikeda, T. 1994: "State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 370-376
Kitamura, M.; Tominaga, T.; Hayashi, K.; Takahashi, I.; Kosaki, G. 1985: Preliminary report of adjuvant chemo-endocrine therapy for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 111-117
Chahine, G.; Howayek, M.; Atallah, D. 2009: Adjuvant endocrine therapy in breast cancer. Management of early-risk relapse Le Journal Medical Libanais. Lebanese Medical Journal 57(2): 124-129
Nomura, Y.; Yamagata, J.; Kondo, H.; Takenaka, K. 1978: Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay Gan 69(2): 281-282
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Zumoff, B. 1992: Adjuvant treatment in breast cancer Lancet 339(8790): 423-424
García-Conde, D.J. 1987: Adjuvant treatment in breast cancer. Ii Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 711
Hess, C.F.; Schmidberger, H. 1998: Adjuvant radiotherapy in the treatment of breast cancer Anticancer Research 18(3c): 2213-2214
Harmer, V. 2000: Adjuvant treatment for breast cancer patients Nursing Times 96(49): 34-35
Russell, I.S. 1977: Adjuvant chemotherapy in the treatment of breast cancer Australian Family Physician 6(6): 629-635
O'Brien, P.H. 1976: Adjuvant treatment in operable breast cancer Journal of the South Carolina Medical Association 72(5): 173-174
Merkel, D.E.; Osborne, C.K. 1989: Adjuvant treatment of node-negative breast cancer Texas Medicine 85(1): 32-36
Barginear, M.F.; Van Poznak, C. 2010: Bisphosphonates: do we know their role in adjuvant breast cancer treatment? Oncology 24(6): 475; 478, 480
Levitt, S.H. 1995: The role of adjuvant therapy in the treatment of breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(11): 661-662
Takada, M.; Ishiguro, H.; Toi, M. 2008: Treatment for breast cancer and endocrine neoplasm Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(13): 2344-2350